semaglutide approved for mash Semaglutide, a GLP-1R agonist, is also effective patients – MedNess Wegovy Gets F.D.A. Approval for
Description
Pfizer drops danuglipron after 1 liver injury, 73% nausea, and 50% dropoutssee why the $150B obesity drug race just got tougher and whos now leading with safer GLP-1 weight loss options.
PlexusDx explains how to optimize nutrition while on GLP-1 therapy to achieve your best results
There's plenty of research happening around the world
Dr Bharadwaj Chada and Dr Michelle Tempest at Candesic consider the trends in the weight loss sector and why now is the time to problem solve, consolidate and invest
Learn how to minimize side effects by starting low and gradually increasing your dose
